Danuta Kalinowski and Des R. Richardson
Год выхода: 2010 г.
Производитель/Издатель: LAP Lambert Academic Publishing
Наличие: Отгружается в течение двух недель
Страниц: 288 стр.
Iron (Fe) chelation therapy involves the use of drugs that avidly bind Fe from biological systems. Iron chelators were developed for the treatment of Fe overload diseases, B-thalassemia and Friedreich''s ataxia. However, the increased requirement for Fe in rapidly proliferating cancer cells, compared to normal cells, makes Fe a target for cancer chemotherapy. Iron chelators remove Fe from Fe-containing proteins, including ribonucleotide reductase, a key enzyme involved in the rate-limiting step of DNA synthesis and inhibit proliferation. Chelators with potent antiproliferative activity also demonstrate the ability to form Fe complexes that redox cycle. This leads to the generation of reactive oxygen species which induce DNA oxidation and mitochondrial damage. The investigations described in this book detail several structural features involved in targeting ligands for either the treatment of Fe overload disease or cancer chemotherapy. These findings emphasise the...
Товары, похожие на «Novel iron chelators for iron overload disease and cancer treatment»
Цена: 7055,00 руб
Цена может отличаться от указанной. Цену уточняйте на сайте OZON.ru